Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sensus Healthcare, Inc. (SRTS : NSDQ)
 
 • Company Description   
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.

Number of Employees: 60

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.03 Daily Weekly Monthly
20 Day Moving Average: 24,384 shares
Shares Outstanding: 16.46 (millions)
Market Capitalization: $49.88 (millions)
Beta: 1.09
52 Week High: $5.92
52 Week Low: $2.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.71% 1.96%
12 Week -23.68% -25.77%
Year To Date -23.87% -31.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
851 BROKEN SOUND PARKWAY NW SUITE 215
-
BOCA RATON,FL 33487
USA		 ph: 561-922-5808
fax: 561-948-2071		 leigh@newstreetir.com http://www.sensushealthcare.com
 
 • General Corporate Information   
Officers
Joseph C. Sardano - Chief Executive Officer and Chairman
Javier Rampolla - Chief Financial Officer
Larry Biscotti - Director
Megan Cornish - Director
Anthony B. Petrelli - Director

Peer Information
Sensus Healthcare, Inc. (ABMD)
Sensus Healthcare, Inc. (DMDS)
Sensus Healthcare, Inc. (CPWY.)
Sensus Healthcare, Inc. (EQUR)
Sensus Healthcare, Inc. (ECIA)
Sensus Healthcare, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81728J109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 16.46
Most Recent Split Date: (:1)
Beta: 1.09
Market Capitalization: $49.88 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.10
Price/Cash Flow: -
Price / Sales: 2.21
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: 15.79%
Sales Growth
vs. Year Ago Period: -59.32%
vs. Previous Quarter: -31.28%
ROE
06/30/26 - -
03/31/26 - -15.79
12/31/25 - -15.11
ROA
06/30/26 - -
03/31/26 - -14.02
12/31/25 - -13.40
Current Ratio
06/30/26 - -
03/31/26 - 7.27
12/31/25 - 9.72
Quick Ratio
06/30/26 - -
03/31/26 - 4.03
12/31/25 - 6.31
Operating Margin
06/30/26 - -
03/31/26 - -34.50
12/31/25 - -28.09
Net Margin
06/30/26 - -
03/31/26 - -34.50
12/31/25 - -28.09
Pre-Tax Margin
06/30/26 - -
03/31/26 - -50.57
12/31/25 - -35.02
Book Value
06/30/26 - -
03/31/26 - 2.77
12/31/25 - 2.93
Inventory Turnover
06/30/26 - -
03/31/26 - 0.87
12/31/25 - 1.02
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©